Aernoud Fiolet

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics The American Heart Journal 2019;218:46-56 S. Mark Nidorf Aernoud T.L. Fiolet John W. Eikelboom Astrid Schut Tjerk S. J. Opstal Willem A Bax Charley A Budgeon Jan G. P. Tijssen Arend Mosterd Jan H. Cornel Peter L. Thompson For the LoDoCo2 Investigators